期刊文献+

心脏术后继发性三尖瓣关闭不全再次行三尖瓣置换术的危险因素分析

Analysis of risk factors of tricuspid valve replacement for patients with secondary tricuspid regurgitation after cardiac surgery
下载PDF
导出
摘要 目的回顾性分析心脏术后三尖瓣关闭不全行三尖瓣置换术死亡危险因素,评价New Euro SCOREⅡ对三尖瓣置换术后风险的预测作用。方法回顾性分析77例心脏术后再次行三尖瓣置换术病例的临床资料,对入选者的临床资料进行单因素及多因素统计学分析。结果单因素分析显示,术前NYHAⅣ级、右心衰、肺动脉压力、总胆红素、肌酐、尿素、尿酸,以及术中体外循环时间、心肌保护液量、升主动脉阻断时间、置换瓣膜大小与术后早期死亡有统计学意义(P<0.05)。术前肌酐升高、无心房颤动是心脏术后再次行三尖瓣置换术早期患者死亡的独立危险因素(P<0.05)。死亡组与非死亡组Euro SCORE评分的差异有统计学意义。结论心脏术后远期因三尖瓣关闭不全行三尖瓣置换术前要特别注意对肾功能异常患者的准备工作,New Euro SCOREⅡ可以作为预测此类手术风险的可靠评分系统。 Objective To retrospectively analyze death risk factors of tricuspid valve replacement for patients with tricuspid regurgitation after cardiac surgery and evaluate the risk prediction of New EuroSCORE Ⅱ after tricuspid valve replacement.Methods The clinical data of 77 patients who underwent the tricuspid valve replacement after cardiac surgery were retrospectively analyzed and univariate analysis and multivariate analysis were conducted.Results The univariate analysis showed that NYHA class Ⅳ,right heart failure,elevated pulmonary artery pressure,total bilirubin,creatinine,urea,uric acid,sinus rhythm,cardiopulmonary bypass time,protection fluid,blocking time,and smaller prosthesis during the operation were statistically significant for early postoperative death(P〈0.05).Elevated creatinine before operation and absence of atrial fibrillation were independent risk factors of early death of patients undergoing the tricuspid valve replacement after cardiac surgery(P〈0.05).The difference of EuroSCORE between the death group and survival group was statistically significant.Conclusion Attention should be paid to patients with abnormal renal function who will undergo the tricuspid valve replacement after cardiac surgery due to tricuspid regurgitation.New EuroSCORE Ⅱ is a reliable scoring system for predicting the risk of operation.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2015年第9期1350-1353,共4页 Journal of Shanghai Jiao tong University:Medical Science
关键词 三尖瓣关闭不全 三尖瓣置换术 危险因素 NEW EuroSCOREⅡ tricuspid regurgitation tricuspid valve replacement risk factors New EuroSCORE Ⅱ
  • 相关文献

参考文献15

  • 1Vahanian A, 0 Alfieri, F Andreotti, et al. Guidelines on the man-agement of valvular heart disease (version 2012). The joint task force on the management of valvular heart disease of the European society of cardiology (ESC) and the European association for cardio- thoracic surgery (EACTS) [ J]. G Ital Cardiol ( Rome), 2013,14 (3): 167 -214.
  • 2Song H, Kim MJ, Chung CH, et aL Factors associated with devel- opment of late significant tricuspid regurgitation after successful left- sided valve surgery[J1. Heart, 2009, 95(11): 931 -936.
  • 3Singh SK, Tang GH, Maganti MD. Midterm outcomes of tricuspid valve repair versus replacement for organic tricuspid disease [ J ] - Ann Thorac Surg, 2006, 82:1735 - 1741.
  • 4Bernal JM, Morales D, Revueha C, et al. Reoperations after tricus- pid valve repair[J].J Thorac Cardiovasc Stlrg, 2005, 130 : 498 - 503.
  • 5Porter A, Shaplra Y, Wurzel M, et al. Tricuspid regurgitation late after mitral valve replacement: clinical and echoeardiographic evalu- ation[J].J Heart Valve Dis, 1999, 8(1): 57 -62.
  • 6Garcla Fuster R, V6zquez A, PehSez AG, eta]. Factors for develop- ment of late significant tricuspid regurgitation after mitral valve replacement : the impact of subvalvular preservation[J].Eur J Car- diothorac Surg, 2011, 39 ( 6 ) : 866 - 874.
  • 7Rogers JH, Boiling SF. The tricuspid valve : current perspective and evolving management of tricuspid regurgitation [ J ]. Circulation, 2009, 119(20) : 2718 -2725.
  • 8Filsoufi F, Anyanwu AC, Salzberg SP, et al. Long-term outcomes of tricuspid valve replacement in the current era [ J ]. Ann Thorac Surg, 2005, 80(3): 845-850.
  • 9Di Mauro M, Bezante GP, Di Baldassarre A, et al. Italian Study Group on Valvular Heart Disease Italian Society of Cardiology. Functional tricuspid regurgitation : an underestimated issue [ J ]. Int J Cardiol, 2013, 168(2): 707 -715.
  • 10Ariyoshi T, Hashizume K, Taniguchi S, et al. Which type of secondary tricuspid regurgitation accompanying mitral valve disease should be surgically treated? [ J] Ann Thorac Cardiovasc Surg, 2013, 19(6) : 428 -434.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部